^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    laprituximab emtansine (IMGN289)

    i
    Other names: IMGN289
    Associations
    News
    Trials
    Company:
    AbbVie
    Drug class:
    Microtubule inhibitor, EGFR-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News
    Trials